Adapromine hydrochloride
- Molecular formula
- C13H21ClN
- CAS Number
- 76144-81-5
- IUPAC Name
- 1-(1-adamantyl)-N-methyl-propan-2-amine;hydrochloride
- Molecular Weight
- 241.77g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1000g/cm3
- Synonyms
- 19835-42-8
Identification
Interesting Facts About 1-(1-Adamantyl)-N-methyl-propan-2-amine; Hydrochloride
The compound 1-(1-adamantyl)-N-methyl-propan-2-amine; hydrochloride represents a fascinating intersection of structural chemistry and pharmacology. Often studied for its potential neuropharmacological effects, this compound is a type of substituted amphetamine. Here are some points that highlight its significance:
- Neurotransmitter Interaction: This compound is believed to act on neurotransmitter systems, particularly affecting the release and reuptake of dopamine and norepinephrine.
- Adamantane Derivative: The adamantyl group in its structure offers unique steric and electronic properties, which may enhance its biological activity compared to simpler amines.
- Psychoactive Research: Investigations into this compound have been driven by its potential as a stimulant and its comparison to other known psychoactive substances.
- Pharmaceutical Applications: Its structure suggests that it may be worth exploring for therapeutic applications in mood disorders, attention deficits, and other neuropsychiatric conditions.
One interesting aspect of its research is the balance between efficacy and safety, as compounds that interact with neurotransmitter systems can lead to diverse outcomes. The study of this compound contributes to our understanding of structure-activity relationships in medicinal chemistry, making it a compelling subject for students and researchers alike.
As chemists continue to unravel the intricacies of such compounds, they remind us that even small molecular modifications can have profound effects on biological activity and therapeutic potential. Thus, 1-(1-adamantyl)-N-methyl-propan-2-amine; hydrochloride serves as a case study in the challenges and opportunities of drug development.